| 注册
首页|期刊导航|现代中医药|基于低氧诱导因子-1α防治肾间质纤维化研究进展

基于低氧诱导因子-1α防治肾间质纤维化研究进展

高志强 崔海霞 崔玉彬 郭兆安 常玲玲

现代中医药2026,Vol.46Issue(3):33-38,6.
✕
现代中医药2026,Vol.46Issue(3):33-38,6.DOI:10.13424/j.cnki.mtcm.2026.03.005

基于低氧诱导因子-1α防治肾间质纤维化研究进展

Research Progress on Therapeutic Approaches for Renal Interstitial Fibrosis and the Pathogenic Role of Hypoxia-Inducible Factor-1α

高志强 1崔海霞 1崔玉彬 1郭兆安 2常玲玲1

作者信息

  • 1. 山东第二医科大学附属益都中心医院,山东 青州 262500
  • 2. 山东省中医院,山东 济南 250014
  • 折叠

摘要

Abstract

Renal interstitial fibrosis(RIF)is the common pathway of chronic kidney disease(CKD),and end-stage renal disease(ESRD)is the end point.Hypoxia-inducible factor-1α(HIF-1α),a key nuclear transcription factor maintai-ning oxygen homeostasis,is activated under hypoxic conditions.The activated HIF-α influences RIF through multiple signa-ling pathways.The article reviews the biological characteristics of HIF-1α,the pathogenesis of RIF,the signaling pathways by which HIF-1α induces RIF,and potential therapeutic targets for RIF,it proposes that HIF-1α plays a crucial role in the process of renal interstitial fibrosis and suggests that targeting HIF-1α represents a promising therapeutic approach.The aim is to offer insights for preventing and treating RIF,improving renal function,and delaying the progression of CKD.

关键词

低氧诱导因子-1α/肾间质纤维化/慢性肾脏病/发病机制/信号通路

Key words

hypoxia inducible factor-1α/renal interstitial fibrosis/chronic kidney disease/pathogenesis/signaling pathway

分类

医药卫生

引用本文复制引用

高志强,崔海霞,崔玉彬,郭兆安,常玲玲..基于低氧诱导因子-1α防治肾间质纤维化研究进展[J].现代中医药,2026,46(3):33-38,6.

基金项目

2024年潍坊市中医药管理局项目(WFZYY-2024-3-007) (WFZYY-2024-3-007)

现代中医药

1672-0571

访问量1
|
下载量0
段落导航相关论文